Stay Informed on Corporate Sustainability

Explore industry news, insights, and updates from the Pharma Industry Awards.

Sort by

Janssen is to rebrand as Johnson & Johnson Innovative Medicine

Author: Chris Wheal

Janssen UK will immediately be known as Johnson & Johnson Innovative Medicine, with Ireland switching over in June.

Ireland’s pharma firms are EU’s third biggest exporter to the rest of the world

Author: Chris Wheal

The latest Eurostat figures show how important Ireland’s pharma sector is.

From Waterford to the world: stability storage firm Q1 Scientific on expansion into Belgium

Author: April Lara

Fresh from The Pharma Industry Awards, Q1 Scientific’s marketing manager, Karrena Legg, shares details on the storage specialist’s strategic move into Belgium.

Pharma and medical device makers have a ‘conflict of interest’ over health education funding

Author: Chris Wheal

Industry denies funding education and research in healthcare organisations presents a conflict of interest.

Irish MEPs urged to back pharma industry and reverse damaging EU legislation

Author: Chris Wheal

The Irish Pharmaceutical Healthcare Association (IPHA) is taking the fight against stifling over-regulation from the EU to the voters

Sparking debate: can the industry do more on energy and transport sustainability?

Author: Chris Wheal

More needs to be done faster to clean up the sector’s emissions. It’s easy to say but hard to achieve

Amie McNeice to lead marketing at Diaceutics on global expansion drive

Author: April Lara

Belfast and London R&D diagnostics firm aims for expansion in the US and Europe

UK companies get injection from first private Covid vaccine clinic

Author: Chris Wheal

The UK’s first non-NHS corporate Covid vaccine clinic gives 10 people the Pfizer jab.

IPHA and IDA Ireland slam EU for making US more attractive than Europe

Author: Chris Wheal

US regulation “has become more agile, more responsive”, while the EU “has moved in the opposite direction”, warns Michael Lohan.

Preventing fraud and corruption in pharma and life sciences

Author: Chris Wheal

Fraud, bribery and corruption are big risks for pharma and life sciences firms – distribution and supply chains across continents are ripe for errors and abuse